| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, namely to oncology and can be applied for treatment of B-cellular lymphoma. Method includes chemotherapy and further treatment of patient by means of radioactively marked anti-CD20 antibody, and patient is not stable to said chemotherapy regimen and does not have a relapse. ^ EFFECT: application of invention allows to increase survival rate of patients due to combined action of radioactively marked anti-CD20 antibody and chemotherapy. ^ 12 cl, 2 ex |
